Aradigm Corp. | Mutual Funds
Mutual Funds that own Aradigm Corp.
Vanguard Total Stock Market Index Fund
229,443
1.51%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
120,486
0.79%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
45,769
0.3%
0
0%
07/31/2018
Lenda de Inversiones, SICAV
41,956
0.28%
41,956
1.53%
03/31/2018
Balaguer 98 de Inversiones, SICAV
20,161
0.13%
20,161
0.71%
03/31/2018
Inver-99, SICAV
20,161
0.13%
20,161
0.69%
03/31/2018
Fidelity Spartan Total Market Index Fund
17,241
0.11%
0
0%
07/31/2018
Fidelity Select Biotechnology Portfolio
11,945
0.08%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
8,569
0.06%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
4,963
0.03%
0
0%
09/06/2018
| Address |
3929 Point Eden Way
Hayward California 94545
United States
|
|
Employees
|
- |
| Website |
http://www.aradigm.com |
| Updated |
09/14/2018 |
| Aradigm Corp. operates as a pharmaceutical company, which focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. Its technologies include diabetes and pain management, AERx essence devices. The company was founded in 1991 and is headquartered in Hayward, CA. |
